Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001434647-26-000034
Filing Date
2026-05-13
Accepted
2026-05-13 16:32:07
Documents
1
Period of Report
2026-05-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1778704324.html 4  
1 FORM 4 wk-form4_1778704324.xml 4 3381
  Complete submission text file 0001434647-26-000034.txt   4967
Mailing Address 101 FEDERAL STREET BOSTON MA 02110
Business Address 101 FEDERAL STREET BOSTON MA 02110 (888) 958-1253
ZEVRA THERAPEUTICS, INC. (Issuer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 233 WILSHIRE BOULEVARD SUITE 280 SANTA MONICA CA 90401
Business Address
Thompson Rahsaan (Reporting) CIK: 0001788524 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36913 | Film No.: 26973943